These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16176811

  • 1. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
    Allanore Y, Kahan A, Sellam J, Ekindjian OG, Borderie D.
    Clin Chim Acta; 2006 Mar; 365(1-2):143-8. PubMed ID: 16176811
    [Abstract] [Full Text] [Related]

  • 2. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M, Nurmohamed MT, Wolbink G, Voskuyl AE, de Koning M, van de Stadt R, Twisk JW, Dijkmans BA, Lems WF.
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [Abstract] [Full Text] [Related]

  • 3. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR, Engstrand S, Berglin E, Johnson O.
    Scand J Rheumatol; 2006 Feb; 35(2):107-11. PubMed ID: 16641043
    [Abstract] [Full Text] [Related]

  • 4. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):1004-7. PubMed ID: 12635469
    [Abstract] [Full Text] [Related]

  • 5. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.
    J Rheumatol; 2006 May 30; 33(5):921-3. PubMed ID: 16541480
    [Abstract] [Full Text] [Related]

  • 6. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT.
    J Rheumatol; 2006 Dec 30; 33(12):2440-6. PubMed ID: 17014005
    [Abstract] [Full Text] [Related]

  • 7. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy.
    Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian OG, Borderie D.
    Clin Chim Acta; 2006 Oct 30; 372(1-2):147-53. PubMed ID: 16716286
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M.
    J Autoimmun; 2008 Sep 30; 31(2):175-9. PubMed ID: 18707846
    [Abstract] [Full Text] [Related]

  • 9. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun 30; 1069():414-9. PubMed ID: 16855168
    [Abstract] [Full Text] [Related]

  • 10. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
    Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF, Dijkmans BA, Twisk JW, de Koning MH, van de Stadt RJ, Nurmohamed MT.
    Ann Rheum Dis; 2007 Jul 30; 66(7):958-61. PubMed ID: 17314120
    [Abstract] [Full Text] [Related]

  • 11. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P.
    Ann Rheum Dis; 2007 Nov 30; 66(11):1503-7. PubMed ID: 17472994
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
    Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL, Radstake TR, Netea MG, Roest M, Stalenhoef AF.
    Ann Rheum Dis; 2009 Jun 30; 68(6):868-72. PubMed ID: 18635596
    [Abstract] [Full Text] [Related]

  • 13. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C, Nolla JM, Valverde J, Gómez-Gerique JA, Castro MJ, Pintó X.
    J Rheumatol; 2009 Jul 30; 36(7):1365-70. PubMed ID: 19369465
    [Abstract] [Full Text] [Related]

  • 14. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
    Saiki O, Takao R, Naruse Y, Kuhara M, Imai S, Uda H.
    J Rheumatol; 2007 Oct 30; 34(10):1997-2004. PubMed ID: 17787045
    [Abstract] [Full Text] [Related]

  • 15. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C, Netea MG, Radstake T, Van der Meer JW, Stalenhoef AF, van Riel PL, Barerra P.
    Ann Rheum Dis; 2005 Feb 30; 64(2):303-5. PubMed ID: 15231512
    [Abstract] [Full Text] [Related]

  • 16. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C, Nolla JM, Valverde J, Narváez J, Corbella E, Pintó X.
    Eur J Clin Invest; 2008 Sep 30; 38(9):686-92. PubMed ID: 18837746
    [Abstract] [Full Text] [Related]

  • 17. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun 30; 1069():420-7. PubMed ID: 16855169
    [Abstract] [Full Text] [Related]

  • 18. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
    Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P.
    J Rheumatol; 2009 Apr 30; 36(4):724-30. PubMed ID: 19273452
    [Abstract] [Full Text] [Related]

  • 19. Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response.
    Pachot A, Arnaud B, Marrote H, Cazalis MA, Diasparra J, Gouraud A, Mougin B, Miossec P.
    J Rheumatol; 2007 Nov 30; 34(11):2158-61. PubMed ID: 17896807
    [Abstract] [Full Text] [Related]

  • 20. Lipid profiles in untreated patients with rheumatoid arthritis.
    Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J.
    J Rheumatol; 1999 Aug 30; 26(8):1701-4. PubMed ID: 10451065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.